vs
IDACORP INC（IDA）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
IDACORP INC的季度营收约是Orthofix Medical Inc.的1.6倍（$360.1M vs $219.9M），IDACORP INC净利率更高（12.1% vs -1.0%，领先13.1%），Orthofix Medical Inc.同比增速更快（2.0% vs -4.2%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-216.2M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -7.2%）
IDACORP Inc是注册于美国爱达荷州、总部设在博伊西的电力控股企业，成立于1998年10月1日，旗下拥有爱达荷电力公司、IDACORP金融公司及Ida-West能源公司，业务覆盖电力供应、能源服务及相关配套金融服务领域。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
IDA vs OFIX — 直观对比
营收规模更大
IDA
是对方的1.6倍
$219.9M
营收增速更快
OFIX
高出6.2%
-4.2%
净利率更高
IDA
高出13.1%
-1.0%
自由现金流更多
OFIX
多$233.0M
$-216.2M
两年增速更快
OFIX
近两年复合增速
-7.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $360.1M | $219.9M |
| 净利润 | $43.6M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 14.9% | 0.2% |
| 净利率 | 12.1% | -1.0% |
| 营收同比 | -4.2% | 2.0% |
| 净利润同比 | 15.1% | 92.4% |
| 每股收益（稀释后） | $0.78 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDAOFIX
| Q4 25 | $360.1M | $219.9M | ||
| Q3 25 | $526.4M | $205.6M | ||
| Q2 25 | $449.3M | $203.1M | ||
| Q1 25 | $411.1M | $193.6M | ||
| Q4 24 | $375.9M | $215.7M | ||
| Q3 24 | $532.5M | $196.6M | ||
| Q2 24 | $442.6M | $198.6M | ||
| Q1 24 | $417.9M | $188.6M |
净利润IDAOFIX
| Q4 25 | $43.6M | $-2.2M | ||
| Q3 25 | $124.4M | $-22.8M | ||
| Q2 25 | $95.8M | $-14.1M | ||
| Q1 25 | $59.6M | $-53.1M | ||
| Q4 24 | $37.9M | $-29.1M | ||
| Q3 24 | $113.6M | $-27.4M | ||
| Q2 24 | $89.5M | $-33.4M | ||
| Q1 24 | $48.2M | $-36.0M |
毛利率IDAOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率IDAOFIX
| Q4 25 | 14.9% | 0.2% | ||
| Q3 25 | 27.5% | -8.3% | ||
| Q2 25 | 22.4% | -7.9% | ||
| Q1 25 | 13.4% | -25.2% | ||
| Q4 24 | 11.0% | -5.3% | ||
| Q3 24 | 25.1% | -9.6% | ||
| Q2 24 | 23.3% | -12.5% | ||
| Q1 24 | 11.9% | -15.6% |
净利率IDAOFIX
| Q4 25 | 12.1% | -1.0% | ||
| Q3 25 | 23.6% | -11.1% | ||
| Q2 25 | 21.3% | -6.9% | ||
| Q1 25 | 14.5% | -27.4% | ||
| Q4 24 | 10.1% | -13.5% | ||
| Q3 24 | 21.3% | -13.9% | ||
| Q2 24 | 20.2% | -16.8% | ||
| Q1 24 | 11.5% | -19.1% |
每股收益（稀释后）IDAOFIX
| Q4 25 | $0.78 | $-0.05 | ||
| Q3 25 | $2.26 | $-0.57 | ||
| Q2 25 | $1.76 | $-0.36 | ||
| Q1 25 | $1.10 | $-1.35 | ||
| Q4 24 | $0.72 | $-0.76 | ||
| Q3 24 | $2.12 | $-0.71 | ||
| Q2 24 | $1.71 | $-0.88 | ||
| Q1 24 | $0.95 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $215.7M | $82.0M |
| 总债务越低越好 | $3.3B | — |
| 股东权益账面价值 | $3.6B | $450.0M |
| 总资产 | $10.2B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.93× | — |
8季度趋势，按日历期对齐
现金及短期投资IDAOFIX
| Q4 25 | $215.7M | $82.0M | ||
| Q3 25 | $333.2M | $62.9M | ||
| Q2 25 | $474.5M | $65.6M | ||
| Q1 25 | $634.5M | $58.0M | ||
| Q4 24 | $368.9M | $83.2M | ||
| Q3 24 | $427.9M | $30.1M | ||
| Q2 24 | $169.6M | $26.4M | ||
| Q1 24 | $157.6M | $27.0M |
总债务IDAOFIX
| Q4 25 | $3.3B | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | $3.1B | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益IDAOFIX
| Q4 25 | $3.6B | $450.0M | ||
| Q3 25 | $3.5B | $442.5M | ||
| Q2 25 | $3.4B | $458.3M | ||
| Q1 25 | $3.3B | $458.3M | ||
| Q4 24 | $3.3B | $503.1M | ||
| Q3 24 | $3.3B | $525.9M | ||
| Q2 24 | $3.2B | $546.0M | ||
| Q1 24 | $2.9B | $570.3M |
总资产IDAOFIX
| Q4 25 | $10.2B | $850.6M | ||
| Q3 25 | $10.1B | $832.6M | ||
| Q2 25 | $9.9B | $837.2M | ||
| Q1 25 | $9.6B | $823.1M | ||
| Q4 24 | $9.2B | $893.3M | ||
| Q3 24 | $9.1B | $867.9M | ||
| Q2 24 | $8.7B | $882.0M | ||
| Q1 24 | $8.3B | $906.0M |
负债/权益比IDAOFIX
| Q4 25 | 0.93× | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | 0.92× | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $137.8M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-216.2M | $16.8M |
| 自由现金流率自由现金流/营收 | -60.0% | 7.6% |
| 资本支出强度资本支出/营收 | 98.3% | 4.9% |
| 现金转化率经营现金流/净利润 | 3.16× | — |
| 过去12个月自由现金流最近4个季度 | $-577.5M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流IDAOFIX
| Q4 25 | $137.8M | $27.7M | ||
| Q3 25 | $162.8M | $12.4M | ||
| Q2 25 | $176.9M | $11.6M | ||
| Q1 25 | $124.3M | $-18.4M | ||
| Q4 24 | $136.4M | $23.7M | ||
| Q3 24 | $201.9M | $11.7M | ||
| Q2 24 | $146.4M | $9.0M | ||
| Q1 24 | $109.7M | $-18.6M |
自由现金流IDAOFIX
| Q4 25 | $-216.2M | $16.8M | ||
| Q3 25 | $-127.9M | $2.5M | ||
| Q2 25 | $-156.4M | $4.5M | ||
| Q1 25 | $-77.0M | $-25.1M | ||
| Q4 24 | $-48.9M | $15.2M | ||
| Q3 24 | $-16.1M | $6.3M | ||
| Q2 24 | $-199.6M | $-360.0K | ||
| Q1 24 | $-150.3M | $-29.1M |
自由现金流率IDAOFIX
| Q4 25 | -60.0% | 7.6% | ||
| Q3 25 | -24.3% | 1.2% | ||
| Q2 25 | -34.8% | 2.2% | ||
| Q1 25 | -18.7% | -13.0% | ||
| Q4 24 | -13.0% | 7.0% | ||
| Q3 24 | -3.0% | 3.2% | ||
| Q2 24 | -45.1% | -0.2% | ||
| Q1 24 | -36.0% | -15.4% |
资本支出强度IDAOFIX
| Q4 25 | 98.3% | 4.9% | ||
| Q3 25 | 55.2% | 4.8% | ||
| Q2 25 | 74.2% | 3.5% | ||
| Q1 25 | 49.0% | 3.5% | ||
| Q4 24 | 49.3% | 4.0% | ||
| Q3 24 | 41.0% | 2.7% | ||
| Q2 24 | 78.2% | 4.7% | ||
| Q1 24 | 62.2% | 5.6% |
现金转化率IDAOFIX
| Q4 25 | 3.16× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 2.08× | — | ||
| Q4 24 | 3.60× | — | ||
| Q3 24 | 1.78× | — | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | 2.28× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDA
| Retailrevenues | $323.0M | 90% |
| Transmissionserviceswheeling | $18.6M | 5% |
| Energyefficiencyprogramrevenues | $11.7M | 3% |
| Wholesaleenergysales | $10.5M | 3% |
| Otherrevenues | $9.5M | 3% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
